These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10860852)

  • 1. VIP activates G(s) and G(i3) in rat alveolar macrophages and G(s) in HEK293 cells transfected with the human VPAC(1) receptor.
    Shreeve SM; Sreedharan SP; Hacker MP; Gannon DE; Morgan MJ
    Biochem Biophys Res Commun; 2000 Jun; 272(3):922-8. PubMed ID: 10860852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of G-proteins coupling to the vasoactive intestinal peptide receptor VPAC(1) using immunoaffinity chromatography: evidence for precoupling.
    Martin Shreeve S
    Biochem Biophys Res Commun; 2002 Feb; 290(4):1300-7. PubMed ID: 11812005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct evidence for functional coupling of the vasoactive intestinal peptide receptor to Gi3 in native lung membranes.
    Diehl NL; Kermode JC; Shreeve SM
    Mol Pharmacol; 1996 Sep; 50(3):624-30. PubMed ID: 8794903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gs and Gq/11 couple vasoactive intestinal peptide and cholinergic stimulation to lacrimal secretion.
    Meneray MA; Fields TY; Bennett DJ
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1261-70. PubMed ID: 9152245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.
    Goursaud S; Pineau N; Becq-Giraudon L; Gressens P; Muller JM; Janet T
    J Neuroimmunol; 2005 Jan; 158(1-2):94-105. PubMed ID: 15589042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a direct interaction between the Thr11 residue of vasoactive intestinal polypeptide and Tyr184 located in the first extracellular loop of the VPAC2 receptor.
    Nachtergael I; Vertongen P; Langer I; Perret J; Robberecht P; Waelbroeck M
    Biochem J; 2003 Mar; 370(Pt 3):1003-9. PubMed ID: 12475394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuropeptide pituitary adenylate cyclase activating polypeptide modulates Ca2+ and pro-inflammatory functions in human monocytes through the G protein-coupled receptors VPAC-1 and formyl peptide receptor-like 1.
    El Zein N; Badran B; Sariban E
    Cell Calcium; 2008 Mar; 43(3):270-84. PubMed ID: 17651798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning and functional expression of a VIP-specific receptor.
    Zhou H; Huang J; Murthy KS
    Am J Physiol Gastrointest Liver Physiol; 2006 Oct; 291(4):G728-34. PubMed ID: 16959956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of G proteins in lacrimal gland.
    Meneray MA; Bennett DJ
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):1173-80. PubMed ID: 7730026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a novel VPAC(1) selective agonist and identification of the receptor domains implicated in the carboxyl-terminal peptide recognition.
    Van Rampelbergh J; Juarranz MG; Perret J; Bondue A; Solano RM; Delporte C; De Neef P; Robberecht P; Waelbroeck M
    Br J Pharmacol; 2000 Jun; 130(4):819-26. PubMed ID: 10864888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidation of the vasoactive intestinal peptide pharmacophore for VPAC(2) receptors in human and rat and comparison to the pharmacophore for VPAC(1) receptors.
    Igarashi H; Ito T; Pradhan TK; Mantey SA; Hou W; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2002 Nov; 303(2):445-60. PubMed ID: 12388623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC(2): role of basic residues in the second transmembrane helix.
    Vertongen P; Solano RM; Perret J; Langer I; Robberecht P; Waelbroeck M
    Br J Pharmacol; 2001 Aug; 133(8):1249-54. PubMed ID: 11498510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies.
    Schulz S; Röcken C; Mawrin C; Weise W; Höllt V; Schulz S
    Clin Cancer Res; 2004 Dec; 10(24):8235-42. PubMed ID: 15623599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ac His1 [D-Phe2, K15, R16, L27] VIP (3-7)/GRF (8-27)--a VPAC1 receptor antagonist--is an inverse agonist on two constitutively active truncated VPAC1 receptors.
    Vertongen P; Langlet C; Langer I; Gaspard N; Robberecht P
    Peptides; 2004 Nov; 25(11):1943-9. PubMed ID: 15501526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
    Rangon CM; Goursaud S; Medja F; Lelièvre V; Mounien L; Husson I; Brabet P; Jégou S; Janet T; Gressens P
    J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium signal-mediated expression of the vasoactive intestinal polypeptide gene and its small contribution to activity-dependent survival of mouse cerebellar granule cells.
    Fukuchi M; Sakuragawa S; Tabuchi A; Tsuda M
    J Neurosci Res; 2004 Jul; 77(1):26-34. PubMed ID: 15197736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tryptophan 67 in the human VPAC(1) receptor: crucial role for VIP binding.
    Nicole P; Maoret JJ; Couvineau A; Momany FA; Laburthe M
    Biochem Biophys Res Commun; 2000 Sep; 276(2):654-9. PubMed ID: 11027527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The polypeptide PHI discriminates a GTP-insensitive form of VIP receptor in liver membranes.
    Pineau N; Lelievre V; Goursaud S; Hilairet S; Waschek JA; Janet T; Muller JM
    Neuropeptides; 2001 Apr; 35(2):117-26. PubMed ID: 11384207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vip-induced cross-talk between G-proteins in membranes from rat anterior pituitary cells.
    Cussac D; Kordon C; Enjalbert A; Saltarelli D
    Cell Signal; 1993 Mar; 5(2):119-37. PubMed ID: 8499223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of vasoactive intestinal peptide receptor subtypes in the lacrimal gland and their signal-transducing components.
    Hodges RR; Zoukhri D; Sergheraert C; Zieske JD; Dartt DA
    Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):610-9. PubMed ID: 9071214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.